These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19016024)

  • 1. Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?
    Vliegen RF; Beets-Tan RG; Vanhauten B; Driessen A; Oellers M; Kessels AG; Arens A; Beets GL; Buijsen J; van Baardwijk A; de Ruysscher D; Lammering G
    Strahlenther Onkol; 2008 Sep; 184(9):457-64. PubMed ID: 19016024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C; Alessi A; Fantini S; Bertarelli G; de Braud F; Bombardieri E; Valvo F; Crippa F; Di Bartolomeo M; Mariani L; Milione M; Biondani P; Avuzzi B; Chiruzzi C; Pietrantonio F
    Oncology; 2013; 84(4):191-9. PubMed ID: 23328390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Chennupati SK; Quon A; Kamaya A; Pai RK; La T; Krakow TE; Graves E; Koong AC; Chang DT
    Am J Clin Oncol; 2012 Aug; 35(4):334-9. PubMed ID: 21422989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
    Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study.
    Goldberg N; Kundel Y; Purim O; Bernstine H; Gordon N; Morgenstern S; Idelevich E; Wasserberg N; Sulkes A; Groshar D; Brenner B
    Radiat Oncol; 2012 Aug; 7():124. PubMed ID: 22853868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY; Jung KH; Kim TH; Kim DW; Chang HJ; Jeong JY; Kim YH; Son SH; Yun T; Hong CW; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):378-84. PubMed ID: 17097835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
    Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of
    Uemura M; Ikeda M; Handa R; Danno K; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Doki Y; Eguchi H
    BMC Cancer; 2021 Oct; 21(1):1132. PubMed ID: 34674666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.
    Elwanis MA; Maximous DW; Elsayed MI; Mikhail NN
    World J Surg Oncol; 2009 Jun; 7():52. PubMed ID: 19508705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
    Konski A; Li T; Sigurdson E; Cohen SJ; Small W; Spies S; Yu JQ; Wahl A; Stryker S; Meropol NJ
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):55-9. PubMed ID: 19004571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.
    Janssen MH; Ollers MC; van Stiphout RG; Buijsen J; van den Bogaard J; de Ruysscher D; Lambin P; Lammering G
    Radiother Oncol; 2010 Feb; 94(2):151-5. PubMed ID: 20116114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer.
    Huh JW; Kwon SY; Lee JH; Kim HR
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):353-9. PubMed ID: 25181962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
    Sun W; Xu J; Hu W; Zhang Z; Shen W
    Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial.
    Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.